None listed
Conditions
Interventions
Intervention1: Herbal Capsule: 500mg capsule containing herbal extract for oral application, 3 times a day for 30 days
Control Intervention1: Nil: Nil
Sponsors
Spectrum Clinical Research Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Healthy volunteers of age 20 to 55 years of either sex who are not involved in any regular medication or supplementation. 2.Subjects having HDL level normal, lower and less than lower range at screening visit. 3.Subjects who are willing to give their written informed consent and comply with the protocol requirements.
Exclusion criteria
Exclusion criteria: 1.Pregnant or lactating women. 2.Subjects with known hypersensitivity to the investigational products. 3.Subjects who have participated in any clinical trial in the past 1 month. 4.Any subjects found to have entered in to the study in violation of this protocol or if the subject is uncooperative during the study. 5.Any other condition that in the opinion of the investigator that does not justify the subjectâ??s participation in the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of treatment on HDL, DHEA and insulin levelTimepoint: 15 and 30 Days from Baseline Visit | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the effect of treatment on following parameters such as TC, VLDL, LDL, TG, TC/HDL ratio, LDL/HDL ratio, Testosterone, Thrombotic (PT and PTT), renal profile, Homocysteine, Estradiol and AMHTimepoint: 30 Days from Baseline Visit | — |
Countries
India
Contacts
Public ContactSanjay Vekariya
Spectrum Healthcare
Outcome results
None listed